Recent 13F filings as of December 2025 show that 48 institutional investors hold a position in Adicet Bio, Inc. (NASDAQ:ACET).
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC | 31 Dec, 2025 | 1,027,944 | 1,027,944 | 0.00% | $8,655,288.00 |
| RA CAPITAL MANAGEMENT, L.P. | 31 Dec, 2025 | 948,249 | 948,249 | 0.00% | $7,984,257.00 |
| FRANKLIN RESOURCES INC | 31 Dec, 2025 | 626,571 | 626,571 | 0.00% | $5,275,728.00 |
| Woodline Partners LP | 31 Dec, 2025 | 625,000 | 625,000 | 0.00% | $5,262,500.00 |
| VANGUARD GROUP INC | 31 Dec, 2025 | 291,277 | 291,277 | 0.00% | $2,452,552.00 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 31 Dec, 2025 | 274,375 | 274,375 | 0.00% | $2,310,238.00 |
| Prosight Management, LP | 31 Dec, 2025 | 250,244 | 250,244 | 0.00% | $2,107,054.00 |
| RENAISSANCE TECHNOLOGIES LLC | 31 Dec, 2025 | 242,945 | 242,945 | 0.00% | $2,045,597.00 |
| GOLDMAN SACHS GROUP INC | 31 Dec, 2025 | 234,510 | 234,510 | 0.00% | $1,974,574.00 |
| Stonepine Capital Management, LLC | 31 Dec, 2025 | 220,011 | 220,011 | 0.00% | $1,852,493.00 |
| Alyeska Investment Group, L.P. | 31 Dec, 2025 | 203,799 | 203,799 | 0.00% | $1,715,988.00 |
| Carlyle Group Inc. | 31 Dec, 2025 | 184,295 | 184,295 | 0.00% | $1,544,391.00 |
| ACADIAN ASSET MANAGEMENT LLC | 31 Dec, 2025 | 181,395 | 181,395 | 0.00% | $1,525.00 |
| NEXTBio Capital Management LP | 31 Dec, 2025 | 157,827 | 157,827 | 0.00% | $1,328,903.00 |
| TWO SIGMA INVESTMENTS, LP | 31 Dec, 2025 | 144,796 | 144,796 | 0.00% | $1,219,182.00 |
| ADAR1 Capital Management, LLC | 31 Dec, 2025 | 128,646 | 128,646 | 0.00% | $1,083,199.00 |
| TWO SIGMA ADVISERS, LP | 31 Dec, 2025 | 111,336 | 111,336 | 0.00% | $937,449.00 |
| CITADEL ADVISORS LLC | 31 Dec, 2025 | 107,814 | 107,814 | 0.00% | $907,794.00 |
| DAFNA Capital Management LLC | 31 Dec, 2025 | 93,812 | 93,812 | 0.00% | $789,897.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Dec, 2025 | 88,856 | 88,856 | 0.00% | $748,270.00 |